Why It Works
Two decades of clinical research.
Proven results, when applied correctly.
Red and near-infrared light has been studied for decades within photobiomodulation and androgenetic alopecia.
The research also shows something important: it is not enough for a device to emit red light. Biological response depends on how the light is delivered – wavelength, dose, treatment time and coverage.
Low-level light therapy is not experimental.
It is one of the few non-invasive treatments with consistent clinical evidence in hair loss.
Red and near-infrared photobiomodulation has been studied for more than 20 years in androgenetic alopecia and scalp health.
Early clinical trials primarily used low-level laser systems.
Today we understand that the biological effect is not determined by the light source, but by how the light is delivered — precisely and consistently.
The outcome depends on controlling these parameters:
- Wavelength accuracy
- Irradiance
- Energy density
- Treatment duration
- Scalp coverage
Dose and Energy Delivery
When these parameters are controlled, the biological response is reproducible.
Energy Density = Irradiance × Time
Dose is what determines the outcome. Not the device. Not the marketing.
Energy density (J/cm²) is the key variable in photobiomodulation.
- Too little → no effect
- Too much → reduced effect
- Correct dose → biological response
The question is not laser versus LED.
The question is engineering precision.
How it works
Light. Delivered precisely. Drives the response.
Light reaches the scalp
Red and near-infrared light penetrates the skin to reach the follicles.
Cells respond to light
Mitochondria increase cellular energy production (ATP).
Growth cycle improves
Follicles stay longer in the growth phase, supporting thicker hair.
It's not just the light
Results depend on how light is delivered — wavelength, dose, and coverage.
Wavelength
Clinically validated red + NIR spectrum
Coverage
Full-scalp delivery, edge to edge
Dose
Controlled energy per session
Consistency
Designed around a sustainable routine
Laser or LED — what actually matters?
The light source alone does not determine the effect. See how wavelength, dose, irradiance, and coverage affect treatment.
How light supports follicle biology
660 nm red light
- Stimulates cellular energy (ATP) in hair follicles
- Supports active growth phase (anagen)
Near-infrared light (RLL-180: 810 nm)
- Penetrates deeper tissue
- May influence local microcirculation
- Studied for effects on inflammatory processes
Hair follicles are energy-dependent structures. Photobiomodulation supports cellular activity and vascular function - it does not force growth.
New to red light therapy for hair loss?
Read our complete guide to how red light therapy for hair loss works, who the treatment is relevant for, and what the research shows.
Guide to red light therapy for hair loss (Norwegian)What controlled studies report
Across randomized and controlled human trials:
- Increased terminal hair density
- Increased shaft thickness
- Reduced shedding
- Improved anagen to telogen ratio
- Improved scalp condition
These findings are reported in controlled studies of both laser-based and LED-based systems. Outcomes depend on factors such as wavelength, dose, irradiance and treatment protocol.
What matters is therefore not the light source alone, but how the treatment is delivered.
Want to go deeper into how this works?
Our knowledge guide explains photobiomodulation, wavelength and dose, LED vs. laser, and what the research actually shows about red light therapy for hair loss.
Read the knowledge guide (Norwegian)From mechanism to clinical evidence
The mechanism explains why photobiomodulation can affect the hair follicle. The decisive question is whether the effect can also be measured in humans.
Here we have collected selected peer-reviewed studies on low-level light therapy (LLLT) for androgenetic alopecia, grouped by evidence level and study design.
About the evidence
The studies below concern low-level light therapy/photobiomodulation and defined treatment parameters. They do not document RLL-180 specifically unless explicitly stated.
Tier 1 — Clinical Human Trials
Highest Level of Clinical Evidence
Peer-reviewed human trials evaluating low-level light therapy (LLLT) for androgenetic alopecia.
Includes randomized controlled trials, split-scalp studies, dual-wavelength protocols, and long-term follow-up.
Male-specific trials
Causes, DHT, common patterns, and what research says about light therapy for male hair loss.
Female-specific trials
Causes, common patterns, and what research says about light therapy for female hair loss.
Dual-wavelength trials
Combination therapy trials
General efficacy and long-term safety trials
Tier 2 — Comparative Evidence
Systematic reviews & meta-analyses
Peer-reviewed analyses comparing low-level light therapy with other hair loss treatments.
Consistently show statistically significant increases in hair density versus control, typically over 16–26 weeks.
Network meta-analyses
Device-specific systematic reviews
Tier 3 — Research and Clinical Evidence
Cellular Mechanisms and Biological Plausibility
Preclinical and translational studies explaining how photobiomodulation supports cellular activity, microcirculation, and follicle function.